It is with immense sadness that Éric Marée, chairman of the executive board of Virbac along with all other members of the executive board must inform you of the death of Pierre Pagès, member of the executive board and head of Worldwide Operations, Thursday 6th February.
Close to Doctor Dick, Pierre was an unstoppable craftsman of the development of Virbac worldwide. The thirty subsidiaries and the one hundred countries in which Virbac operates today are largely the result of his fierce determination to plant the Virbac flag and prosper the business of the Group throughout the world.
Profoundly human, remarkable in his humility and simplicity, but also in his tenacity, his humorous streak was never far away. He leaves an immense void in the Virbac family.
Pierre Pagès was a veterinarian by training and a MBA graduated of the HEC business school. He started his career with Cyanamid before joining Reading Laboratories as product manager in 1980. He was then promoted to director of Marketing before taking responsibility for the worldwide business operations of Virbac in 1990. He joined the executive board in 1992, and became head of Worldwide Operations in 1996.
The reallocation of the reporting lines of the executive board members that was implemented temporarily end of 2013 will be confirmed by the supervisory board during its next meeting scheduled on March 18.
Éric Marée is therefore responsible for supervising Group Industrial operations department, French Industrial department and the Corporate Sourcing.
Christian Karst, executive vice-president Corporate development, supervises the Corporate Quality Assurance department and holds the position of Qualified Person of Virbac in line with articles L5142-1 and seq of the French public health code. Sébastien Huron becomes head of Global Business Operations. The reporting lines and functions of the other members have not changed.
Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families:
- pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips;
- livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc.
Net sales are distributed geographically as follows: France (15.8%), Europe (24.9%), Asia (17.5%), Latin America (16.2%), North America (13.3%), Pacific (9.7%), Africa and Middle East (2.6%).
VIRBAC 
By 
